Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Extended Follow up of a Phase 2b Vaccine Trial With RTS,S/AS01E in Kilifi District, Kenya.

NCT00872963 is registered in ClinicalTrials.gov with KEMRI-Wellcome Trust Collaborative Research Program as lead sponsor.

NCT NCT00872963
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00872963 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Extended Follow up of a Phase 2b Vaccine Trial With RTS,S/AS01E in Kilifi District, Kenya.
Lead sponsor
KEMRI-Wellcome Trust Collaborative Research Program
Phase
Observational
Overall status
Unknown status
Start date
February 28, 2009
Completion date
August 31, 2016
Enrollment
450 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malaria